intoDNA to participate in the 2nd Annual Targeted Radiopharmaceuticals Summit US (TRP)
KRAKÓW, POLAND, 11, July 2023 – intoDNA will be participating in the 2nd Annual
TRP Summit US in Boston, MA July 25-27
intoDNA is proud to partner with the 2nd annual TRP Summit in participation with
industry leaders in Radiopharma and Nuclear Medicine. Dr Brian Patterson, Chief
Commercial Officer at intoDNA, will discuss how STRIDE technology can help
accelerate the understanding of drug induced DNA damage through direct sensitive
measurement of single and double stranded DNA breaks in situ. intoDNA will be
exhibiting at booth #14. Stop by to learn about 2 new assays in the STRIDE portfolio,
STRIDE-HR and STRIDE-MMR, launched earlier this yr.